Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: A confirmatory evidence of HCV exposure

Transfusion

Volumn 49, Issue 7, 2009, Pages 1296-1305

  Sauleda, Sílvia ^a   Bes, Marta ^b   Esteban, Juan Ignacio ^b   Casamitjana, Natàlia ^b   Piron, Maria ^b   Quer, Josep ^b   Cubero, María ^b   Puig, Lluís ^b   Guardia, Jaime ^b  

^a Transfusion Safety Laboratory   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; CYTOKINE; GAMMA INTERFERON; HELICASE; INTERLEUKIN 2; NONSTRUCTURAL PROTEIN 3; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN NS3 HELICASE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS RNA;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BLOOD DONOR; CELL CULTURE; CONTROLLED STUDY; COUNSELING; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; MALE; QUANTITATIVE ANALYSIS; SCREENING TEST; SEROTYPE; SUPERNATANT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

BLOOD DONORS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; IMMUNITY, CELLULAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTYPING; T-LYMPHOCYTES;

EID: 67649970377     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02103.x     Document Type: Article

References (44)

1. Lauer GM, Walker BD Hepatitis C virus infection. N Engl J Med 2001 345 : 41 52. (Pubitemid 32634271)
2. Bowen DG, Walker CM. Adaptative immune response in acute and chronic HCV infection. Nature 2005 436 : 946 51.
3. Neumann-Haefelin C, Blum HE, Chisari FV, Thimme R. T cell response in hepatitis C virus infection. J Clin Virol 2005 32 : 75 85. (Pubitemid 40093957)
4. Bigger CB, Brasky KM, Landford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C. J Virol 2001 120 : 955 66.
5. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, Gavindarajan S, Purcell RH, Chisari FV. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 2002 99 : 15661 8.
6. Major ME, Mihalik K, Puig M, Rehermann B, Nascimbeni M, Rice CM, Feinstone SM. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol 2002 76 : 6586 95.
7. Major ME, Dahari H, Mihalik K, Puig M, Rice CM, Neumann AU, Feinstone SM. Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees. Hepatology 2004 39 : 1709 20.
8. Gerlach JT, Ulsenheimer A, Gruner NH, Jung MC, Schraut W, Schirren CA, Heeq M, Scholz S, Witter K, Zahn R, Vogler A, Zachoval R, Pape GR, Diepolder HM. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J Virol 2005 79 : 12425 33.
9. Schulze zur Wiesch J, Lauer GM, Day CL, Kim AY, Ouchi K, Duncan JE, Wurcel AG, Timm J, Jones AM, Mothe B, Allen TM, McGovern B, Lewis-Ximenez L, Sidney J, Sette A, Chung RT, Walker BD. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 2005 175 : 3603 13.
10. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, Pape GR. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995 346 : 1006 7.
11. Gerlach JT, Diepolder HM, Jung MC, Gruner NH, Schraut WW, Zachoval R, Hoffmann R, Schirren CA, Santantonio T, Pape GR. Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C. Gastroenterology 1999 117 : 933 41.
12. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, Schraut WW, Schirren CA, Waechtler M, Backmund M, Pape GR. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003 125 : 80 8.
13. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001 194 : 1395 406.
14. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD. Analysis of successful immune responses in persons infected with HCV. J Exp Med 2000 191 : 1499 512.
15. Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, Kim AY, Day CL, Robbins GK, Casson DR, Reiser M, Dusheiko G, Allen TM, Chung RT, Walker BD, Klenerman P. High resolution analysis of cellular immune responses in resolved and persistent HCV infection. Gastroenterology 2004 127 : 924 36.
16. Aberle JH, Formann E, Steindl-Munda P, Weseslintner L, Gurguta C, Perstinger G, Grilnberger E, Laferl H, Dienes HP, Popow-Kraupp T, Ferenci P, Holzmann H. Prospective study of viral clearance and CD4 (+) T-cell response in acute hepatitis C primary infection and reinfection. J Clin Virol 2006 36 : 24 31. (Pubitemid 44360574)
17. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997 25 : 449 58.
18. Semmo N, Day CL, Ward SM, Lucas M, Harcourt G, Loughry A, Klenerman P. Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 2005 41 : 1019 28.
19. Semmo N, Krashias G, Willberg C, Klenerman P. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection. J Viral Hepat 2007 14 : 492 502. (Pubitemid 46944474)
20. Semmo N, Klenerman P. CD4+ T cell responses in hepatitis C virus infection. Gastroenterology 2007 13 : 4831 8.
21. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller JL, Manns MP, Rehermann B. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000 6 : 578 82.
22. Koziel MJ, Wong DK, Dudley D, Houghton M, Walker BD Hepatitis C virus - specific cytolytic T lymphocytes and T helper cell responses in seronegative persons. J Infect Dis 1997 176 : 859 66.
23. Bronowicki JP, Vetter D, Uhl G, Hudziak H, Uhrlacher A, Vetter JM. Lymphocyte reactivity to hepatitis C virus infection (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J Infect Dis 1997 176 : 518 22.
24. Kamal SM, Amin A, Madwar M, Graham CS, He Q, Al Tawil A, Rasenack J, Nakano T, Robertson B, Ismail A, Koziel MJ. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol 2004 78 : 12252 8.
25. Busch M, Glynn S, Stramer S, Orland J, Murphy EL, Wright DJ, Kleinman S. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Transfusion 2006 46 : 469 75.
26. Kubitschke A, Bahr MJ, Aslan N, Bader C, Tillmann HL, Sarrazin C, Greten T, Wiegand J, Manns MP, Wedemeyer H. Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia. Eur J Clin Invest 2007 37 : 54 64. (Pubitemid 44934773)
27. Fang CT, Tobler LH, Haesche C, Busch MP, Phelps B, Leparc G. Fluctuation of HCV viral load before seroconversion in a healthy volunteer blood donor. Transfusion 2003 43 : 541 4.
28. Dow BC, Munro H, Buchanan I, Follett EA, Davidson F, Yap PL, Simmonds P. Third-generation recombinant immunoblot assay: comparison of reactivities according to hepatitis C virus genotype. Transfusion 1996 36 : 547 51.
29. Kanistanon D, Neelamek M, Dharakul T, Songsivilai S. The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays. Asian Pac J Allergy Immunol 1997 15 : 133 40.
30. Halfon P, Bourliere M, Khiri H, Halimi G, Gerolami V, Feryn JM, Feryn JM, Ouzan D. Serological response to infection with different isolates of hepatitis C virus. J Viral Hepat 2002 9 : 438 42.
31. Allain JP, Kitchen A, Aloysius S, Reeves I, Petrik J, Barbara JM, Williamson LM. Safety and efficacy of hepatitis C virus antibody screening of blood donors with two sequential screening assays. Transfusion 1996 36 : 401 5.
32. Dow BC, Buchanan I, Munro H, Follett EA, Davidson F, Prescott LE, Yap PL, Simmonds P. Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors. J Med Virol 1996 49 : 132 6.
33. Lemaire JM, Courouce AM, Defer C, Bouchardeau F, Coste J, Agulles O, Cantaloube JF, Barlet V, Barin F. HCV RNA in blood donors with isolated reactivities by third-generation RIBA. Transfusion 2000 40 : 867 70.
34. Kiely P, Kay D, Parker S, Piscitelli L. The significance of third-generation HCV RIBA-indeterminate, HCV RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays. Transfusion 2004 44 : 349 58.
35. Kitchen AD, Tucker NV. The specificity of anti-HCV supplementary assays. Vox Sang 1995 69 : 100 3.
36. Howell DR, Webster MH, Barbara JA. Retrospective follow up of recipients and donors of blood donations reactive for anti-HBc or for single HCV antibodies. Transfus Med 2000 10 : 265 9.
37. Pawlotsky JM, Bastie A, Pellet C, Remire J, Darthuy F, Wolfe L, Sayada C, Duval J, Dhumeaux D. Significance of third generation hepatitis C virus recombinant immunoblot assay. J Clin Microbiol 1996 34 : 80 3.
38. Tobler LH, Busch MP, Wilber J, Dinello R, Quan S, Polito A, Kochesky R, Bahl C, Nelles M, Lee SR. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors. Transfusion 1994 34 : 130 4.
39. Leon P, Lopez JA, Elola C, Domingo CJ, Echevarria JM. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV. Vox Sang 1996 70 : 213 6.
40. Leon P, Lopez JA, Elola C, Lee SR, Calmann M, Echevarria JM. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen. Vox Sang 1998 75 : 32 6.
41. Semmo N, Barnes E, Taylor C, Kurtz J, Harcourt G, Smith N, Klenerman P. T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet 2005 365 : 327 9.
42. Wedemeyer H, Mizukoshi E, Davis AR, Bennink JR, Rehermann B. Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells. J Virol 2001 75 : 11392 400.
43. Cl D, Seth NP, Lucas M, Appel H, Gauthier L, Lauer GM, Robbins GK, Szczepiorkowski ZM, Casson DR, Chung RT, Bell S, Harcourt G, Walker BD, Klenerman P, Wucherpfennig KW. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest 2003 112 : 831 42.
44. Frentsch M, Olga A, Kirchhoff D, Moewes B, Worm M, Rothe M, Scheffold A, Thiel A. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med 2005 11 : 1118 24.